SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
DiscoverDIVISLAB.NS
HealthcareNSEINR

Divi's Laboratories

₹00123456789,001234567890012345678900123456789.0012345678900123456789+9.3%
52w low (est.) ₹6,039.37₹8,969.79 52w high (est.)
Peers
Market data
Market cap
₹1.81T
52-week range
₹5,636.50 – ₹7,330.00
Beta (vs market)
0.22
Sector
Healthcare
Valuation
P/E ratio
70.4x
DCF fair value
₹2,805.32
Margin of safety
-61.5%
Forward P/E
48.6x
Dividend yield
0.44%
Quality & efficiency
Moat score
83/100
Return on equity
16.2%
Profit margin
24.3%
Growth & analysts
Revenue growth (YoY)
+9.5%
Analyst target
₹7,088.80
Target upside
-2.7%
Analysts covering
30

About Divi's Laboratories

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Valuation

ValueGrowthProfitHealthIncome43QUALITY
Overall Rating
43
Reduce
Reduce
Moat Score83
DCF Intrinsic Value
₹2,805.32-61.5% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
₹1.81T
P/E Ratio
70.4
Dividend Yield
0.44%
Revenue Growth
+9.5%
Profit Margin
24.3%
ROE
16.2%
Debt / Equity
0.00
Beta
0.22
Momentum
vs Healthcare sector:P/E 70 vs 28 Moat 83 vs 7Yield 0.44% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · DIVISLAB.NS